Citigroup’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $153M | Buy |
2,128,000
+1,787,100
| +524% | +$138M | 0.07% | 277 |
|
|
2025
Q4 | $27.1M | Sell |
340,900
-161,000
| -32% | -$12.7M | 0.01% | 943 |
|
|
2025
Q3 | $37.8M | Sell |
501,900
-402,600
| -45% | -$27.6M | 0.02% | 755 |
|
|
2025
Q2 | $62.4M | Buy |
904,500
+377,600
| +72% | +$24.8M | 0.03% | 515 |
|
|
2025
Q1 | $35.7M | Sell |
526,900
-73,300
| -12% | -$4.39M | 0.02% | 701 |
|
|
2024
Q4 | $26.9M | Buy |
600,200
+372,100
| +163% | +$20.9M | 0.02% | 799 |
|
|
2024
Q3 | $14.3M | Buy |
+228,100
| New | +$13.3M | 0.01% | 1136 |
|
|
2024
Q1 | – | Sell |
-307,500
| Closed | -$24.3M | – | 5672 |
|
|
2023
Q4 | $24.3M | Sell |
307,500
-37,500
| -11% | -$2.67M | 0.02% | 756 |
|
|
2023
Q3 | $24.1M | Sell |
345,000
-126,500
| -27% | -$8.96M | 0.02% | 697 |
|
|
2023
Q2 | $32.6M | Buy |
471,500
+92,500
| +24% | +$6.58M | 0.02% | 605 |
|
|
2023
Q1 | $28.2M | Buy |
379,000
+175,000
| +86% | +$14.7M | 0.02% | 643 |
|
|
2022
Q4 | $19M | Buy |
204,000
+75,000
| +58% | +$7.24M | 0.02% | 822 |
|
|
2022
Q3 | $12.3M | Sell |
129,000
-235,000
| -65% | -$23.3M | 0.01% | 1045 |
|
|
2022
Q2 | $33.7M | Buy |
364,000
+173,500
| +91% | +$16.9M | 0.03% | 547 |
|
|
2022
Q1 | $19.3M | Sell |
190,500
-644,800
| -77% | -$67.7M | 0.01% | 966 |
|
|
2021
Q4 | $86.2M | Buy |
835,300
+485,300
| +139% | +$44.8M | 0.05% | 359 |
|
|
2021
Q3 | $29.7M | Buy |
350,000
+80,000
| +30% | +$6.7M | 0.02% | 777 |
|
|
2021
Q2 | $22.5M | Sell |
270,000
-53,400
| -17% | -$4.37M | 0.01% | 935 |
|
|
2021
Q1 | $24.3M | Sell |
323,400
-821,800
| -72% | -$59.9M | 0.02% | 848 |
|
|
2020
Q4 | $78.2M | Buy |
1,145,200
+283,200
| +33% | +$18.4M | 0.05% | 352 |
|
|
2020
Q3 | $50.3M | Buy |
862,000
+39,400
| +5% | +$2.45M | 0.03% | 450 |
|
|
2020
Q2 | $53.4M | Buy |
822,600
+20,500
| +3% | +$1.29M | 0.04% | 377 |
|
|
2020
Q1 | $47.6M | Sell |
802,100
-89,769
| -10% | -$5.99M | 0.04% | 376 |
|
|
2019
Q4 | $66.3M | Sell |
891,869
-308,309
| -26% | -$21.6M | 0.05% | 379 |
|
|
2019
Q3 | $75.7M | Buy |
1,200,178
+460,795
| +62% | +$27.3M | 0.06% | 309 |
|
|
2019
Q2 | $40.3M | Buy |
739,383
+51,081
| +7% | +$2.75M | 0.03% | 544 |
|
|
2019
Q1 | $37.1M | Buy |
688,302
+239,479
| +53% | +$14.8M | 0.04% | 514 |
|
|
2018
Q4 | $29.4M | Buy |
448,823
+83,223
| +23% | +$6.21M | 0.03% | 618 |
|
|
2018
Q3 | $28.8M | Sell |
365,600
-640,900
| -64% | -$45.8M | 0.03% | 633 |
|
|
2018
Q2 | $64.8M | Buy |
1,006,500
+799,200
| +386% | +$52.7M | 0.06% | 280 |
|
|
2018
Q1 | $12.9M | Sell |
207,300
-125,300
| -38% | -$8.99M | 0.01% | 1067 |
|
|
2017
Q4 | $24.1M | Buy |
332,600
+4,900
| +1% | +$356K | 0.02% | 745 |
|
|
2017
Q3 | $26.6M | Buy |
327,700
+45,800
| +16% | +$3.62M | 0.02% | 668 |
|
|
2017
Q2 | $22.7M | Sell |
281,900
-201,400
| -42% | -$15.9M | 0.02% | 697 |
|
|
2017
Q1 | $37.9M | Buy |
483,300
+161,600
| +50% | +$12.9M | 0.03% | 468 |
|
|
2016
Q4 | $25.4M | Sell |
321,700
-20,300
| -6% | -$1.64M | 0.02% | 636 |
|
|
2016
Q3 | $30.4M | Sell |
342,000
-39,100
| -10% | -$3.69M | 0.03% | 514 |
|
|
2016
Q2 | $36.5M | Buy |
381,100
+43,600
| +13% | +$4.35M | 0.04% | 412 |
|
|
2016
Q1 | $35M | Sell |
337,500
-7,900
| -2% | -$768K | 0.04% | 399 |
|
|
2015
Q4 | $33.8M | Buy |
345,400
+38,100
| +12% | +$3.73M | 0.03% | 498 |
|
|
2015
Q3 | $29.6M | Sell |
307,300
-30,000
| -9% | -$3.15M | 0.03% | 536 |
|
|
2015
Q2 | $35.4M | Sell |
337,300
-114,500
| -25% | -$11.7M | 0.03% | 509 |
|
|
2015
Q1 | $46.6M | Buy |
451,800
+78,700
| +21% | +$7.96M | 0.05% | 384 |
|
|
2014
Q4 | $35.9M | Buy |
373,100
+114,800
| +44% | +$10.1M | 0.03% | 536 |
|
|
2014
Q3 | $20.6M | Buy |
258,300
+104,800
| +68% | +$8.26M | 0.02% | 787 |
|
|
2014
Q2 | $11.6M | Buy |
153,500
+25,200
| +20% | +$1.9M | 0.01% | 1161 |
|
|
2014
Q1 | $9.61M | Sell |
128,300
-266,800
| -68% | -$18.8M | 0.01% | 1187 |
|
|
2013
Q4 | $28.3M | Buy |
395,100
+9,700
| +3% | +$623K | 0.03% | 604 |
|
|
2013
Q3 | $21.9M | Buy |
385,400
+16,800
| +5% | +$1M | 0.02% | 699 |
|
|
2013
Q2 | $21.1M | Buy |
+368,600
| New | +$21.4M | 0.02% | 670 |
|
Other funds holding CVS
VCM
VPM
Citigroup's CVS Position: Q1 2026 in Review
Citigroup increased its CVS Health (CVS) stake by 25% in Q1 2026, buying an estimated $30.7M and bringing the position to 1,986,793 shares worth $143M. The position accounts for 0.06% of the portfolio, ranked #293.
Citigroup first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $341M in Q1 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Citigroup held 1,986,793 shares of CVS Health worth $143M as of Q1 2026.
- Citigroup bought 398,103 CVS Health shares in Q1 2026, an estimated $30.7M.
- CVS Health made up 0.06% of Citigroup's portfolio in Q1 2026, its #293 holding.
- Citigroup first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Citigroup's CVS Health position peaked at $341M in Q1 2022.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.